Logo image of NCNO

NCINO INC (NCNO) Stock Fundamental Analysis

NASDAQ:NCNO - Nasdaq - US63947X1019 - Common Stock - Currency: USD

28.82  -0.04 (-0.14%)

Premarket: 29.9 +1.08 (+3.75%)

Fundamental Rating

3

Overall NCNO gets a fundamental rating of 3 out of 10. We evaluated NCNO against 282 industry peers in the Software industry. NCNO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NCNO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

NCNO had positive earnings in the past year.
In the past year NCNO had a positive cash flow from operations.
NCNO had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: NCNO reported negative operating cash flow in multiple years.
NCNO Yearly Net Income VS EBIT VS OCF VS FCFNCNO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

1.2 Ratios

NCNO's Return On Assets of -1.78% is in line compared to the rest of the industry. NCNO outperforms 59.93% of its industry peers.
NCNO has a better Return On Equity (-2.74%) than 62.77% of its industry peers.
Industry RankSector Rank
ROA -1.78%
ROE -2.74%
ROIC N/A
ROA(3y)-4.42%
ROA(5y)-4.85%
ROE(3y)-5.85%
ROE(5y)-6.34%
ROIC(3y)N/A
ROIC(5y)N/A
NCNO Yearly ROA, ROE, ROICNCNO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30

1.3 Margins

NCNO's Gross Margin of 60.05% is on the low side compared to the rest of the industry. NCNO is outperformed by 60.28% of its industry peers.
In the last couple of years the Gross Margin of NCNO has grown nicely.
NCNO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.42%
GM growth 5Y2.3%
NCNO Yearly Profit, Operating, Gross MarginsNCNO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

4

2. Health

2.1 Basic Checks

NCNO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NCNO has been increased compared to 1 year ago.
The number of shares outstanding for NCNO has been increased compared to 5 years ago.
NCNO has a worse debt/assets ratio than last year.
NCNO Yearly Shares OutstandingNCNO Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
NCNO Yearly Total Debt VS Total AssetsNCNO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

NCNO has an Altman-Z score of 3.46. This indicates that NCNO is financially healthy and has little risk of bankruptcy at the moment.
NCNO's Altman-Z score of 3.46 is fine compared to the rest of the industry. NCNO outperforms 61.70% of its industry peers.
The Debt to FCF ratio of NCNO is 5.06, which is a neutral value as it means it would take NCNO, 5.06 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 5.06, NCNO perfoms like the industry average, outperforming 58.16% of the companies in the same industry.
A Debt/Equity ratio of 0.24 indicates that NCNO is not too dependend on debt financing.
NCNO has a Debt to Equity ratio (0.24) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 5.06
Altman-Z 3.46
ROIC/WACCN/A
WACC10.76%
NCNO Yearly LT Debt VS Equity VS FCFNCNO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

NCNO has a Current Ratio of 1.05. This is a normal value and indicates that NCNO is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.05, NCNO is not doing good in the industry: 72.34% of the companies in the same industry are doing better.
A Quick Ratio of 1.05 indicates that NCNO should not have too much problems paying its short term obligations.
The Quick ratio of NCNO (1.05) is worse than 71.28% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
NCNO Yearly Current Assets VS Current LiabilitesNCNO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

5

3. Growth

3.1 Past

NCNO shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
Looking at the last year, NCNO shows a quite strong growth in Revenue. The Revenue has grown by 13.40% in the last year.
NCNO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.37% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.79%
Revenue 1Y (TTM)13.4%
Revenue growth 3Y25.44%
Revenue growth 5Y31.37%
Sales Q2Q%12.53%

3.2 Future

NCNO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.92% yearly.
Based on estimates for the next years, NCNO will show a quite strong growth in Revenue. The Revenue will grow by 8.98% on average per year.
EPS Next Y9.87%
EPS Next 2Y19.37%
EPS Next 3Y22.92%
EPS Next 5YN/A
Revenue Next Year7.61%
Revenue Next 2Y8.15%
Revenue Next 3Y8.98%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NCNO Yearly Revenue VS EstimatesNCNO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
NCNO Yearly EPS VS EstimatesNCNO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 45.75, NCNO can be considered very expensive at the moment.
Based on the Price/Earnings ratio, NCNO is valued a bit cheaper than 61.70% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.41. NCNO is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 30.65, the valuation of NCNO can be described as expensive.
64.18% of the companies in the same industry are more expensive than NCNO, based on the Price/Forward Earnings ratio.
NCNO is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 35.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 45.75
Fwd PE 30.65
NCNO Price Earnings VS Forward Price EarningsNCNO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as NCNO.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NCNO is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 64.77
EV/EBITDA 151.07
NCNO Per share dataNCNO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NCNO does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as NCNO's earnings are expected to grow with 22.92% in the coming years.
PEG (NY)4.64
PEG (5Y)N/A
EPS Next 2Y19.37%
EPS Next 3Y22.92%

0

5. Dividend

5.1 Amount

No dividends for NCNO!.
Industry RankSector Rank
Dividend Yield N/A

NCINO INC

NASDAQ:NCNO (7/11/2025, 8:00:02 PM)

Premarket: 29.9 +1.08 (+3.75%)

28.82

-0.04 (-0.14%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-28 2025-05-28/amc
Earnings (Next)N/A N/A
Inst Owners114.91%
Inst Owner Change0%
Ins Owners1.41%
Ins Owner Change19.58%
Market Cap3.34B
Analysts71.3
Price Target30.96 (7.43%)
Short Float %11.01%
Short Ratio6.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-19.26%
Min EPS beat(2)-36.6%
Max EPS beat(2)-1.92%
EPS beat(4)2
Avg EPS beat(4)-0.66%
Min EPS beat(4)-36.6%
Max EPS beat(4)28.46%
EPS beat(8)6
Avg EPS beat(8)20.37%
EPS beat(12)9
Avg EPS beat(12)17.38%
EPS beat(16)13
Avg EPS beat(16)21.27%
Revenue beat(2)1
Avg Revenue beat(2)-0.6%
Min Revenue beat(2)-1.59%
Max Revenue beat(2)0.4%
Revenue beat(4)1
Avg Revenue beat(4)-0.78%
Min Revenue beat(4)-1.59%
Max Revenue beat(4)0.4%
Revenue beat(8)1
Avg Revenue beat(8)-0.95%
Revenue beat(12)3
Avg Revenue beat(12)-0.52%
Revenue beat(16)7
Avg Revenue beat(16)0.4%
PT rev (1m)0.71%
PT rev (3m)-26.22%
EPS NQ rev (1m)-1.02%
EPS NQ rev (3m)-10.28%
EPS NY rev (1m)1.51%
EPS NY rev (3m)-18.82%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-0.8%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)-0.09%
Valuation
Industry RankSector Rank
PE 45.75
Fwd PE 30.65
P/S 6
P/FCF 64.77
P/OCF 60.67
P/B 3.12
P/tB N/A
EV/EBITDA 151.07
EPS(TTM)0.63
EY2.19%
EPS(NY)0.94
Fwd EY3.26%
FCF(TTM)0.44
FCFY1.54%
OCF(TTM)0.48
OCFY1.65%
SpS4.8
BVpS9.25
TBVpS-1.46
PEG (NY)4.64
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.78%
ROE -2.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.05%
FCFM 9.27%
ROA(3y)-4.42%
ROA(5y)-4.85%
ROE(3y)-5.85%
ROE(5y)-6.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.42%
GM growth 5Y2.3%
F-Score5
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 5.06
Debt/EBITDA 11.29
Cap/Depr 9.01%
Cap/Sales 0.63%
Interest Coverage N/A
Cash Conversion 239.84%
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 3.46
F-Score5
WACC10.76%
ROIC/WACCN/A
Cap/Depr(3y)23.11%
Cap/Depr(5y)36.46%
Cap/Sales(3y)1.95%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.79%
EPS Next Y9.87%
EPS Next 2Y19.37%
EPS Next 3Y22.92%
EPS Next 5YN/A
Revenue 1Y (TTM)13.4%
Revenue growth 3Y25.44%
Revenue growth 5Y31.37%
Sales Q2Q%12.53%
Revenue Next Year7.61%
Revenue Next 2Y8.15%
Revenue Next 3Y8.98%
Revenue Next 5YN/A
EBIT growth 1Y48.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year23.17%
EBIT Next 3Y25.04%
EBIT Next 5YN/A
FCF growth 1Y3539%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y275.44%
OCF growth 3YN/A
OCF growth 5YN/A